Odyssean LLC’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.47M Sell
2,713
-2,732
-50% -$1.41M 0.17% 206
2026
Q2
$2.95M Buy
5,445
+2,358
+76% +$1.33M 0.48% 61
2026
Q1
$1.83M Buy
3,087
+1,588
+106% +$791K 0.67% 1
2025
Q4
$730K Buy
+1,499
New +$698K 0.52% 108

Other funds holding UTHR

Odyssean LLC's UTHR Position: Q3 2026 in Review

Odyssean LLC reduced its United Therapeutics (UTHR) stake by 50% in Q3 2026, selling an estimated $1.41M and leaving 2,713 shares worth $1.47M. The position accounts for 0.17% of the portfolio, ranked #206.

Odyssean LLC first reported a position in UTHR in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.95M in Q2 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Odyssean LLC held 2,713 shares of United Therapeutics worth $1.47M as of Q3 2026.
  • Odyssean LLC sold 2,732 United Therapeutics shares in Q3 2026, an estimated $1.41M.
  • United Therapeutics made up 0.17% of Odyssean LLC's portfolio in Q3 2026, its #206 holding.
  • Odyssean LLC first reported a position in United Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Odyssean LLC's United Therapeutics position peaked at $2.95M in Q2 2026.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.